An increase in circulating ANGPL4, by contrast, was observed in all the obese phenotypes, irrespective of the absence or presence of metabolic abnormalities, even though the rise in circulating ANGPTL4 was more pronounced in the patients with T2D than in those with MHO and MUO. This evidence concerns the gene ANGPTL4 and type 2 diabetes mellitus.